Characterized by recurring expected or unexpected panic attacks, worry about future attacks over a 1-month period, and changes in behavior as a consequence of the attacks.
Higher risk among first-degree relatives; onset of attacks triggered by stress; often comorbid with other anxiety, mood, and substance-use disorders.
Assessment is made through ruling out organic causes; self-report; clinical interview; and behavioral observation.
Selective serotonin-reuptake inhibitors, serotonin-norepinephrine reuptake inhibitors, and cognitive behavioral psychotherapy are first-line treatments; benzodiazepines may be used cautiously in patients without comorbid depression.
Long-term management includes relapse prevention after treatment discontinuation.
Epocrates, Inc. All Rights Reserved.
Epocrates iPhone Epocrates Android Epocrates Palm Epocrates Free Download
Epocrates Institutional Sales Epocrates Market Research Epocrates CME Epocrates Mobile Resource Centers Epocrates Clinical Content